Herbal medicinal product: Symphyti radixArray, F: Assessment finalised
Submitted by Anonymous (not verified) on 11 March 2024 - 12:03
Herbal medicinal product: Symphyti radixArray, F: Assessment finalised
Agenda of the COMP meeting 12-14 March 2024
Submitted by Anonymous (not verified) on 11 March 2024 - 10:53
Agenda of the COMP meeting 12-14 March 2024
Committee for Medicinal Products for Human Use (CHMP): 22-25 January 2024, European Medicines Agency, Amsterdam, the Netherlands, from 22 January 2024 to 25 January 2024
Submitted by Anonymous (not verified) on 11 March 2024 - 10:28
Committee for Medicinal Products for Human Use (CHMP): 22-25 January 2024, European Medicines Agency, Amsterdam, the Netherlands, from 22 January 2024 to 25 January 2024
Product-specific bioequivalence guidance
Submitted by Anonymous (not verified) on 11 March 2024 - 10:28
Product-specific bioequivalence guidance
Minutes of the CHMP meeting 22-25 January 2024
Submitted by Anonymous (not verified) on 11 March 2024 - 10:26
Minutes of the CHMP meeting 22-25 January 2024
Procedural advice for orphan medicinal product designation: Guidance for sponsors
Submitted by Anonymous (not verified) on 11 March 2024 - 9:48
Procedural advice for orphan medicinal product designation: Guidance for sponsors
Fludarabine supply shortage
Submitted by Anonymous (not verified) on 11 March 2024 - 9:39
Fludarabine supply shortage
Opinion/decision on a Paediatric investigation plan (PIP): Imbruvica, Ibrutinib, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Immunology-Rheumatology-Transplantation, PIP number: P/0421/2019
Submitted by Anonymous (not verified) on 8 March 2024 - 15:02
Opinion/decision on a Paediatric investigation plan (PIP): Imbruvica, Ibrutinib, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Immunology-Rheumatology-Transplantation, PIP number: P/0421/2019
EMEA-001312-PIP02-19
Submitted by Anonymous (not verified) on 8 March 2024 - 14:57
EMEA-001312-PIP02-19
EMEA-001312-PIP03-19
Submitted by Anonymous (not verified) on 8 March 2024 - 14:55
EMEA-001312-PIP03-19